Colorectal Cancer – Pipeline Review, H2 2016

Global Markets Direct’s, ‘Colorectal Cancer – Pipeline Review, H2 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colorectal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Colorectal Cancer

The report reviews pipeline therapeutics for Colorectal Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Colorectal Cancer therapeutics and enlists all their major and minor projects

The report assesses Colorectal Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Colorectal Cancer

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Colorectal Cancer

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Colorectal Cancer pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

2cureX ApS

3-V Biosciences Inc

3M Drug Delivery Systems

3SBio Inc

4SC AG

AB Science SA

AbbVie Inc

AbGenomics International Inc

Accelerated Pharma Inc

Adamed Sp z oo

Aduro BioTech Inc

Advenchen Laboratories LLC

Alchemia Ltd

Allinky Biopharma

Amal Therapeutics SA

amcure GmbH

Amgen Inc

Antibe Therapeutics Inc

Apac Biotech Pvt Ltd

Apexigen Inc

Aphios Corp

Aposense Ltd

Arisaph Pharmaceuticals Inc

ARMO Biosciences Inc

ArQule Inc

Array BioPharma Inc

Asana BioSciences LLC

Aslan Pharmaceuticals Pte Ltd

Astellas Pharma Inc

Astex Pharmaceuticals Inc

AstraZeneca Plc

ATLAB Pharma SAS

AVEO Pharmaceuticals Inc

B Cell Design SAS

Basilea Pharmaceutica Ltd

Bavarian Nordic A/S

Bayer AG

BeiGene Ltd

BeyondSpring Pharmaceuticals Inc

Biocon Ltd

Bionomics Ltd

Bionovis SA

Biotecnol Ltd

Biothera Pharmaceutical Inc

Boehringer Ingelheim GmbH

Boston Biomedical Inc

Bristol-Myers Squibb Company

Burzynski Research Institute Inc

Calithera Biosciences Inc

Cancer Prevention Pharmaceuticals Inc

Carna Biosciences Inc

Cascadian Therapeutics Inc

CBT Pharmaceuticals Inc

CCRP Therapeutics GmbH

Celgene Corp

Cellceutix Corp

Celldex Therapeutics Inc

Cellectar Biosciences Inc

Celltrion Inc

Celyad SA

Chiome Bioscience Inc

Chipscreen Biosciences Ltd

ChoDang Pharm Co Ltd

Cipla Ltd

Cleave Biosciences Inc

Cleveland BioLabs Inc

COARE Biotechnology Inc

Coherus BioSciences Inc

Compugen Ltd

Cornerstone Pharmaceuticals Inc

Corvus Pharmaceuticals Inc

Critical Outcome Technologies Inc

CrystalGenomics Inc

Cytune Pharma SAS

Daiichi Sankyo Company Ltd

DanDrit Biotech A/S

Deciphera Pharmaceuticals LLC

Dicerna Pharmaceuticals Inc

Double Bond Pharmaceutical International AB

Dr. Reddy's Laboratories Ltd

EirGenix Inc

Eisai Co Ltd

Eli Lilly and Company

Endor Nanotechnologies SL

enGene Inc

EnGeneIC Ltd

Ensol Biosciences Inc

EntreChem SL

Enzo Biochem Inc

Etubics Corp

Exelixis Inc

F. Hoffmann-La Roche Ltd

Five Prime Therapeutics Inc

Formosa Laboratories Inc

Fusion Antibodies Ltd

Gene Techno Science Co Ltd

Genentech Inc

Genor BioPharma Co Ltd

Genoscience Pharma

Genzyme Corp

Gilead Sciences Inc

GlaxoSmithKline Plc

Glycotope GmbH

Golden Biotechnology Corp

Green Cross Corp

Hadasit Medical Research Services & Development Ltd

Handok Inc

Hanmi Pharmaceuticals Co Ltd

Heat Biologics Inc

Hemispherx Biopharma Inc

Hutchison MediPharma Ltd

iDD biotech SAS

Ideaya Biosciences Inc

Ignyta Inc

Immodulon Therapeutics Ltd

ImmuneXcite Inc

Immunomedics Inc

Immunovative Therapies Ltd

Incanthera Ltd

Incyte Corp

Innovent Biologics Inc

Inovio Pharmaceuticals Inc

Interprotein Corp

Intezyne Technologies Inc

Ionis Pharmaceuticals Inc

IPD Therapeutics BV

Isofol Medical AB

Jeil Pharmaceutical Co Ltd

JHL Biotech Inc

Jiangsu Hengrui Medicine Co Ltd

Johnson & Johnson

KaloBios Pharmaceuticals Inc

Kancera AB

Karyopharm Therapeutics Inc

Kura Oncology Inc

Laboratorio ELEA SACIF y A

Lee's Pharmaceutical Holdings Ltd

Lion Biotechnologies Inc

LipoMedix Pharmaceutical Inc

Loxo Oncology, Inc.

Mabion SA

Mabtech Ltd

mAbxience SA

MacroGenics Inc

Marina Biotech Inc

MediaPharma srl

MedImmune LLC

Medinet Co Ltd

Merck & Co Inc

Merck KGaA

Merrimack Pharmaceuticals Inc

Merus NV

Microlin Bio, Inc.

MolMed SpA

Mologen AG

Morphotek Inc

Multimmune GmbH

Mycenax Biotech Inc

Natco Pharma Ltd

NatureWise Biotech & Medicals Corp

Nektar Therapeutics

Neovacs SA

Nerviano Medical Sciences Srl

Nippon Kayaku Co Ltd

NormOxys Inc

Northwest Biotherapeutics Inc

Novartis AG

Novogen Ltd

Noxxon Pharma AG

NuCana BioMed Ltd

OBI Pharma Inc

Oncobiologics Inc

Oncolytics Biotech Inc

OncoMed Pharmaceuticals Inc

Onconova Therapeutics Inc

Ono Pharmaceutical Co Ltd

Oryx GmbH & Co KG

Otsuka Holdings Co Ltd

Oxford BioMedica Plc

Pfizer Inc

Pharma Mar SA

PharmAbcine Inc

Pivot Pharmaceuticals Inc

Pivotal BioSciences Inc

PlantForm Corp

PLx Pharma Inc

Precision Biologics Inc

Prima BioMed Ltd

Propanc Health Group Corp

Provectus Biopharmaceuticals Inc

PsiOxus Therapeutics Ltd

Puma Biotechnology Inc

R Pharm

RedHill Biopharma Ltd

Redx Pharma Plc

Regeneron Pharmaceuticals Inc

Rexahn Pharmaceuticals Inc

Rgenix Inc

Rhizen Pharmaceuticals SA

Richter Gedeon Nyrt

Samumed LLC

Sanofi

Selvita SA

Shanghai Henlius Biotech Co Ltd

Shire Plc

Sigma-Tau SpA

Sigmoid Pharma Ltd

Sillajen Biotherapeutics

Solvotrin Therapeutics Ltd

Sorrento Therapeutics Inc

Sumitomo Dainippon Pharma Co Ltd

SuviCa Inc

Symphogen A/S

Synermore Biologics Co Ltd

Taiho Pharmaceutical Co Ltd

TaiwanJ Pharmaceuticals Co Ltd

Takeda Pharmaceutical Company Ltd

Tara Immuno-Oncology Therapeutics LLC

Targovax ASA

Tarveda Therapeutics Inc

Theravectys SA

Tiltan Pharma Ltd

Tocagen Inc

TRACON Pharmaceuticals Inc

Transgene SA

TyrNovo Ltd

United BioPharma Inc

Vaccinex Inc

VasGene Therapeutics Inc

Vaximm AG

Verastem Inc

Vertex Pharmaceuticals Inc

Viralytics Ltd

Wilex AG

WntResearch AB

XBiotech Inc

XuanZhu Pharma Co Ltd

Zymeworks Inc

Table of Contents

Table of Contents

Table of Contents 2

Introduction 12

Colorectal Cancer Overview 13

Therapeutics Development 14

Colorectal Cancer - Therapeutics under Development by Companies 16

Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes 36

Colorectal Cancer - Pipeline Products Glance 38

Colorectal Cancer - Products under Development by Companies 42

Colorectal Cancer - Products under Investigation by Universities/Institutes 71

Colorectal Cancer - Companies Involved in Therapeutics Development 74

Colorectal Cancer - Therapeutics Assessment 312

Drug Profiles 359

Colorectal Cancer - Dormant Projects 1545

Colorectal Cancer - Discontinued Products 1576

Colorectal Cancer - Product Development Milestones 1584

Appendix 1593

List of Tables

List of Tables

Number of Products under Development for Colorectal Cancer, H2 2016 65

Number of Products under Development for Colorectal Cancer – Comparative Analysis, H2 2016 66

Number of Products under Development by Companies, H2 2016 68

Number of Products under Development by Companies, H2 2016 (Contd..1) 69

Number of Products under Development by Companies, H2 2016 (Contd..2) 70

Number of Products under Development by Companies, H2 2016 (Contd..3) 71

Number of Products under Development by Companies, H2 2016 (Contd..4) 72

Number of Products under Development by Companies, H2 2016 (Contd..5) 73

Number of Products under Development by Companies, H2 2016 (Contd..6) 74

Number of Products under Development by Companies, H2 2016 (Contd..7) 75

Number of Products under Development by Companies, H2 2016 (Contd..8) 76

Number of Products under Development by Companies, H2 2016 (Contd..9) 77

Number of Products under Development by Companies, H2 2016 (Contd..10) 78

Number of Products under Development by Companies, H2 2016 (Contd..11) 79

Number of Products under Development by Companies, H2 2016 (Contd..12) 80

Number of Products under Development by Companies, H2 2016 (Contd..13) 81

Number of Products under Development by Companies, H2 2016 (Contd..14) 82

Number of Products under Development by Companies, H2 2016 (Contd..15) 83

Number of Products under Development by Companies, H2 2016 (Contd..16) 84

Number of Products under Development by Companies, H2 2016 (Contd..17) 85

Number of Products under Development by Companies, H2 2016 (Contd..18) 86

Number of Products under Investigation by Universities/Institutes, H2 2016 87

Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 88

Comparative Analysis by Late Stage Development, H2 2016 89

Comparative Analysis by Clinical Stage Development, H2 2016 90

Comparative Analysis by Early Stage Development, H2 2016 91

Comparative Analysis by Unknown Stage Development, H2 2016 92

Products under Development by Companies, H2 2016 93

Products under Development by Companies, H2 2016 (Contd..1) 94

Products under Development by Companies, H2 2016 (Contd..2) 95

Products under Development by Companies, H2 2016 (Contd..3) 96

Products under Development by Companies, H2 2016 (Contd..4) 97

Products under Development by Companies, H2 2016 (Contd..5) 98

Products under Development by Companies, H2 2016 (Contd..6) 99

Products under Development by Companies, H2 2016 (Contd..7) 100

Products under Development by Companies, H2 2016 (Contd..8) 101

Products under Development by Companies, H2 2016 (Contd..9) 102

Products under Development by Companies, H2 2016 (Contd..10) 103

Products under Development by Companies, H2 2016 (Contd..11) 104

Products under Development by Companies, H2 2016 (Contd..12) 105

Products under Development by Companies, H2 2016 (Contd..13) 106

Products under Development by Companies, H2 2016 (Contd..14) 107

Products under Development by Companies, H2 2016 (Contd..15) 108

Products under Development by Companies, H2 2016 (Contd..16) 109

Products under Development by Companies, H2 2016 (Contd..17) 110

Products under Development by Companies, H2 2016 (Contd..18) 111

Products under Development by Companies, H2 2016 (Contd..19) 112

Products under Development by Companies, H2 2016 (Contd..20) 113

Products under Development by Companies, H2 2016 (Contd..21) 114

Products under Development by Companies, H2 2016 (Contd..22) 115

Products under Development by Companies, H2 2016 (Contd..23) 116

Products under Development by Companies, H2 2016 (Contd..24) 117

Products under Development by Companies, H2 2016 (Contd..25) 118

Products under Development by Companies, H2 2016 (Contd..26) 119

Products under Development by Companies, H2 2016 (Contd..27) 120

Products under Development by Companies, H2 2016 (Contd..28) 121

Products under Investigation by Universities/Institutes, H2 2016 122

Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 123

Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 124

Colorectal Cancer – Pipeline by 2cureX ApS, H2 2016 125

Colorectal Cancer – Pipeline by 3-V Biosciences Inc, H2 2016 126

Colorectal Cancer – Pipeline by 3M Drug Delivery Systems, H2 2016 127

Colorectal Cancer – Pipeline by 3SBio Inc, H2 2016 128

Colorectal Cancer – Pipeline by 4SC AG, H2 2016 129

Colorectal Cancer – Pipeline by AB Science SA, H2 2016 130

Colorectal Cancer – Pipeline by AbbVie Inc, H2 2016 131

Colorectal Cancer – Pipeline by AbGenomics International Inc, H2 2016 132

Colorectal Cancer – Pipeline by Accelerated Pharma Inc, H2 2016 133

Colorectal Cancer – Pipeline by Adamed Sp z oo, H2 2016 134

Colorectal Cancer – Pipeline by Aduro BioTech Inc, H2 2016 135

Colorectal Cancer – Pipeline by Advenchen Laboratories LLC, H2 2016 136

Colorectal Cancer – Pipeline by Alchemia Ltd, H2 2016 137

Colorectal Cancer – Pipeline by Allinky Biopharma, H2 2016 138

Colorectal Cancer – Pipeline by Amal Therapeutics SA, H2 2016 139

Colorectal Cancer – Pipeline by amcure GmbH, H2 2016 140

Colorectal Cancer – Pipeline by Amgen Inc, H2 2016 141

Colorectal Cancer – Pipeline by Antibe Therapeutics Inc, H2 2016 142

Colorectal Cancer – Pipeline by Apac Biotech Pvt Ltd, H2 2016 143

Colorectal Cancer – Pipeline by Apexigen Inc, H2 2016 144

Colorectal Cancer – Pipeline by Aphios Corp, H2 2016 145

Colorectal Cancer – Pipeline by Aposense Ltd, H2 2016 146

Colorectal Cancer – Pipeline by Arisaph Pharmaceuticals Inc, H2 2016 147

Colorectal Cancer – Pipeline by ARMO Biosciences Inc, H2 2016 148

Colorectal Cancer – Pipeline by ArQule Inc, H2 2016 149

Colorectal Cancer – Pipeline by Array BioPharma Inc, H2 2016 150

Colorectal Cancer – Pipeline by Asana BioSciences LLC, H2 2016 151

Colorectal Cancer – Pipeline by Aslan Pharmaceuticals Pte Ltd, H2 2016 152

Colorectal Cancer – Pipeline by Astellas Pharma Inc, H2 2016 153

Colorectal Cancer – Pipeline by Astex Pharmaceuticals Inc, H2 2016 154

Colorectal Cancer – Pipeline by AstraZeneca Plc, H2 2016 155

Colorectal Cancer – Pipeline by ATLAB Pharma SAS, H2 2016 156

Colorectal Cancer – Pipeline by AVEO Pharmaceuticals Inc, H2 2016 157

Colorectal Cancer – Pipeline by B Cell Design SAS, H2 2016 158

Colorectal Cancer – Pipeline by Basilea Pharmaceutica Ltd, H2 2016 159

Colorectal Cancer – Pipeline by Bavarian Nordic A/S, H2 2016 160

Colorectal Cancer – Pipeline by Bayer AG, H2 2016 161

Colorectal Cancer – Pipeline by BeiGene Ltd, H2 2016 162

Colorectal Cancer – Pipeline by BeyondSpring Pharmaceuticals Inc, H2 2016 163

Colorectal Cancer – Pipeline by Biocon Ltd, H2 2016 164

Colorectal Cancer – Pipeline by Bionomics Ltd, H2 2016 165

Colorectal Cancer – Pipeline by Bionovis SA, H2 2016 166

Colorectal Cancer – Pipeline by Biotecnol Ltd, H2 2016 167

Colorectal Cancer – Pipeline by Biothera Pharmaceutical Inc, H2 2016 168

Colorectal Cancer – Pipeline by Boehringer Ingelheim GmbH, H2 2016 169

Colorectal Cancer – Pipeline by Boston Biomedical Inc, H2 2016 170

Colorectal Cancer – Pipeline by Bristol-Myers Squibb Company, H2 2016 171

Colorectal Cancer – Pipeline by Burzynski Research Institute Inc, H2 2016 172

Colorectal Cancer – Pipeline by Calithera Biosciences Inc, H2 2016 173

Colorectal Cancer – Pipeline by Cancer Prevention Pharmaceuticals Inc, H2 2016 174

Colorectal Cancer – Pipeline by Carna Biosciences Inc, H2 2016 175

Colorectal Cancer – Pipeline by Cascadian Therapeutics Inc, H2 2016 176

Colorectal Cancer – Pipeline by CBT Pharmaceuticals Inc, H2 2016 177

Colorectal Cancer – Pipeline by CCRP Therapeutics GmbH, H2 2016 178

Colorectal Cancer – Pipeline by Celgene Corp, H2 2016 179

Colorectal Cancer – Pipeline by Cellceutix Corp, H2 2016 180

Colorectal Cancer – Pipeline by Celldex Therapeutics Inc, H2 2016 181

Colorectal Cancer – Pipeline by Cellectar Biosciences Inc, H2 2016 182

Colorectal Cancer – Pipeline by Celltrion Inc, H2 2016 183

Colorectal Cancer – Pipeline by Celyad SA, H2 2016 184

Colorectal Cancer – Pipeline by Chiome Bioscience Inc, H2 2016 185

Colorectal Cancer – Pipeline by Chipscreen Biosciences Ltd, H2 2016 186

Colorectal Cancer – Pipeline by ChoDang Pharm Co Ltd, H2 2016 187

Colorectal Cancer – Pipeline by Cipla Ltd, H2 2016 188

Colorectal Cancer – Pipeline by Cleave Biosciences Inc, H2 2016 189

Colorectal Cancer – Pipeline by Cleveland BioLabs Inc, H2 2016 190

Colorectal Cancer – Pipeline by COARE Biotechnology Inc, H2 2016 191

Colorectal Cancer – Pipeline by Coherus BioSciences Inc, H2 2016 192

Colorectal Cancer – Pipeline by Compugen Ltd, H2 2016 193

Colorectal Cancer – Pipeline by Cornerstone Pharmaceuticals Inc, H2 2016 194

Colorectal Cancer – Pipeline by Corvus Pharmaceuticals Inc, H2 2016 195

Colorectal Cancer – Pipeline by Critical Outcome Technologies Inc, H2 2016 196

Colorectal Cancer – Pipeline by CrystalGenomics Inc, H2 2016 197

Colorectal Cancer – Pipeline by Cytune Pharma SAS, H2 2016 198

Colorectal Cancer – Pipeline by Daiichi Sankyo Company Ltd, H2 2016 199

Colorectal Cancer – Pipeline by DanDrit Biotech A/S, H2 2016 200

Colorectal Cancer – Pipeline by Deciphera Pharmaceuticals LLC, H2 2016 201

Colorectal Cancer – Pipeline by Dicerna Pharmaceuticals Inc, H2 2016 202

Colorectal Cancer – Pipeline by Double Bond Pharmaceutical International AB, H2 2016 203

Colorectal Cancer – Pipeline by Dr. Reddy's Laboratories Ltd, H2 2016 204

Colorectal Cancer – Pipeline by EirGenix Inc, H2 2016 205

Colorectal Cancer – Pipeline by Eisai Co Ltd, H2 2016 206

Colorectal Cancer – Pipeline by Eli Lilly and Company, H2 2016 207

Colorectal Cancer – Pipeline by Endor Nanotechnologies SL, H2 2016 208

Colorectal Cancer – Pipeline by enGene Inc, H2 2016 209

Colorectal Cancer – Pipeline by EnGeneIC Ltd, H2 2016 210

Colorectal Cancer – Pipeline by Ensol Biosciences Inc, H2 2016 211

Colorectal Cancer – Pipeline by EntreChem SL, H2 2016 212

Colorectal Cancer – Pipeline by Enzo Biochem Inc, H2 2016 213

Colorectal Cancer – Pipeline by Etubics Corp, H2 2016 214

Colorectal Cancer – Pipeline by Exelixis Inc, H2 2016 215

Colorectal Cancer – Pipeline by F. Hoffmann-La Roche Ltd, H2 2016 216

Colorectal Cancer – Pipeline by Five Prime Therapeutics Inc, H2 2016 217

Colorectal Cancer – Pipeline by Formosa Laboratories Inc, H2 2016 218

Colorectal Cancer – Pipeline by Gene Techno Science Co Ltd, H2 2016 220

Colorectal Cancer – Pipeline by Genentech Inc, H2 2016 221

Colorectal Cancer – Pipeline by Genor BioPharma Co Ltd, H2 2016 222

Colorectal Cancer – Pipeline by Genoscience Pharma, H2 2016 223

Colorectal Cancer – Pipeline by Genzyme Corp, H2 2016 224

Colorectal Cancer – Pipeline by Gilead Sciences Inc, H2 2016 225

Colorectal Cancer – Pipeline by GlaxoSmithKline Plc, H2 2016 226

Colorectal Cancer – Pipeline by Glycotope GmbH, H2 2016 227

Colorectal Cancer – Pipeline by Golden Biotechnology Corp, H2 2016 228

Colorectal Cancer – Pipeline by Green Cross Corp, H2 2016 229

Colorectal Cancer – Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2016 230

Colorectal Cancer – Pipeline by Handok Inc, H2 2016 231

Colorectal Cancer – Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2016 232

Colorectal Cancer – Pipeline by Heat Biologics Inc, H2 2016 233

Colorectal Cancer – Pipeline by Hemispherx Biopharma Inc, H2 2016 234

Colorectal Cancer – Pipeline by Hutchison MediPharma Ltd, H2 2016 235

Colorectal Cancer – Pipeline by iDD biotech SAS, H2 2016 236

Colorectal Cancer – Pipeline by Ideaya Biosciences Inc, H2 2016 237

Colorectal Cancer – Pipeline by Ignyta Inc, H2 2016 238

Colorectal Cancer – Pipeline by Immodulon Therapeutics Ltd, H2 2016 239

Colorectal Cancer – Pipeline by ImmuneXcite Inc, H2 2016 240

Colorectal Cancer – Pipeline by Immunomedics Inc, H2 2016 241

Colorectal Cancer – Pipeline by Immunovative Therapies Ltd, H2 2016 242

Colorectal Cancer – Pipeline by Incanthera Ltd, H2 2016 243

Colorectal Cancer – Pipeline by Incyte Corp, H2 2016 244

Colorectal Cancer – Pipeline by Innovent Biologics Inc, H2 2016 245

Colorectal Cancer – Pipeline by Inovio Pharmaceuticals Inc, H2 2016 246

Colorectal Cancer – Pipeline by Interprotein Corp, H2 2016 247

Colorectal Cancer – Pipeline by Intezyne Technologies Inc, H2 2016 248

Colorectal Cancer – Pipeline by Ionis Pharmaceuticals Inc, H2 2016 249

Colorectal Cancer – Pipeline by IPD Therapeutics BV, H2 2016 250

Colorectal Cancer – Pipeline by Isofol Medical AB, H2 2016 251

Colorectal Cancer – Pipeline by Jeil Pharmaceutical Co Ltd, H2 2016 252

Colorectal Cancer – Pipeline by JHL Biotech Inc, H2 2016 253

Colorectal Cancer – Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2016 254

Colorectal Cancer – Pipeline by Johnson & Johnson, H2 2016 255

Colorectal Cancer – Pipeline by KaloBios Pharmaceuticals Inc, H2 2016 256

Colorectal Cancer – Pipeline by Kancera AB, H2 2016 257

Colorectal Cancer – Pipeline by Karyopharm Therapeutics Inc, H2 2016 258

Colorectal Cancer – Pipeline by Kura Oncology Inc, H2 2016 259

Colorectal Cancer – Pipeline by Laboratorio ELEA SACIF y A, H2 2016 260

Colorectal Cancer – Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2016 261

Colorectal Cancer – Pipeline by Lion Biotechnologies Inc, H2 2016 262

Colorectal Cancer – Pipeline by LipoMedix Pharmaceutical Inc, H2 2016 263

Colorectal Cancer – Pipeline by Loxo Oncology, Inc., H2 2016 264

Colorectal Cancer – Pipeline by Mabion SA, H2 2016 265

Colorectal Cancer – Pipeline by Mabtech Ltd, H2 2016 266

Colorectal Cancer – Pipeline by mAbxience SA, H2 2016 267

Colorectal Cancer – Pipeline by MacroGenics Inc, H2 2016 268

Colorectal Cancer – Pipeline by Marina Biotech Inc, H2 2016 269

Colorectal Cancer – Pipeline by MediaPharma srl, H2 2016 270

Colorectal Cancer – Pipeline by MedImmune LLC, H2 2016 271

Colorectal Cancer – Pipeline by Medinet Co Ltd, H2 2016 272

Colorectal Cancer – Pipeline by Merck & Co Inc, H2 2016 273

Colorectal Cancer – Pipeline by Merck KGaA, H2 2016 274

Colorectal Cancer – Pipeline by Merrimack Pharmaceuticals Inc, H2 2016 275

Colorectal Cancer – Pipeline by Merus NV, H2 2016 276

Colorectal Cancer – Pipeline by Microlin Bio, Inc., H2 2016 277

Colorectal Cancer – Pipeline by MolMed SpA, H2 2016 278

Colorectal Cancer – Pipeline by Mologen AG, H2 2016 279

Colorectal Cancer – Pipeline by Morphotek Inc, H2 2016 280

Colorectal Cancer – Pipeline by Multimmune GmbH, H2 2016 281

Colorectal Cancer – Pipeline by Mycenax Biotech Inc, H2 2016 282

Colorectal Cancer – Pipeline by Natco Pharma Ltd, H2 2016 283

Colorectal Cancer – Pipeline by NatureWise Biotech & Medicals Corp, H2 2016 284

Colorectal Cancer – Pipeline by Nektar Therapeutics, H2 2016 285

Colorectal Cancer – Pipeline by Neovacs SA, H2 2016 286

Colorectal Cancer – Pipeline by Nerviano Medical Sciences Srl, H2 2016 287

Colorectal Cancer – Pipeline by Nippon Kayaku Co Ltd, H2 2016 288

Colorectal Cancer – Pipeline by NormOxys Inc, H2 2016 289

Colorectal Cancer – Pipeline by Northwest Biotherapeutics Inc, H2 2016 290

Colorectal Cancer – Pipeline by Novartis AG, H2 2016 291

Colorectal Cancer – Pipeline by Novogen Ltd, H2 2016 292

Colorectal Cancer – Pipeline by Noxxon Pharma AG, H2 2016 293

Colorectal Cancer – Pipeline by NuCana BioMed Ltd, H2 2016 294

Colorectal Cancer – Pipeline by OBI Pharma Inc, H2 2016 295

Colorectal Cancer – Pipeline by Oncobiologics Inc, H2 2016 296

Colorectal Cancer – Pipeline by Oncolytics Biotech Inc, H2 2016 297

Colorectal Cancer – Pipeline by OncoMed Pharmaceuticals Inc, H2 2016 298

Colorectal Cancer – Pipeline by Onconova Therapeutics Inc, H2 2016 299

Colorectal Cancer – Pipeline by Ono Pharmaceutical Co Ltd, H2 2016 300

List of Figures

List of Figures

Number of Products under Development for Colorectal Cancer, H2 2016 65

Number of Products under Development for Colorectal Cancer – Comparative Analysis, H2 2016 66

Number of Products under Development by Companies, H2 2016 67

Number of Products under Investigation by Universities/Institutes, H2 2016 87

Comparative Analysis by Late Stage Development, H2 2016 89

Comparative Analysis by Clinical Stage Development, H2 2016 90

Comparative Analysis by Early Stage Products, H2 2016 91

Assessment by Monotherapy Products, H2 2016 363

Assessment by Combination Products, H2 2016 364

Number of Products by Top 10 Targets, H2 2016 365

Number of Products by Stage and Top 10 Targets, H2 2016 365

Number of Products by Top 10 Mechanism of Actions, H2 2016 385

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 385

Number of Products by Top 10 Routes of Administration, H2 2016 406

Number of Products by Stage and Top 10 Routes of Administration, H2 2016 406

Number of Products by Top 10 Molecule Types, H2 2016 408

Number of Products by Stage and Top 10 Molecule Types, H2 2016 408

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports